Although GVHD is closely related to GVT effects after allo-HCT, murine models utilizing MHC class II–deficient but class I+ tumors effectively separate CD4+ T cell–mediated GVHD from CD8+ T cell–mediated GVT (22). The gene discussed is CD8A; the disease is graft versus host disease.